Abstract: Described herein are examples of orthopedic drill bits and methods of preparing a bone of a living being for fixation. An example method includes coupling a drive attachment of a drill bit to a mounting attachment of a driver, and placing a guide at a desired location on the bone. The guide has an opening corresponding to an area of bone to be removed. The guide provides proper positioning and alignment for drilling a hole. With the guide in place, the method further includes aligning the drill bit with the opening on the guide and drilling a hole in the bone. Once the hole is drilled, the method includes de-coupling the drill bit from the driver, and bending the drill bit at the drive attachment while the drill bit is still in the bone. In some examples, additional method steps follow preparation of the hole.

Abstract: In some examples, a medical device delivery system includes a device cup configured to retain the medical device at the distal end of a catheter, the cup having a cylindrical body defining at least one vent hole extending from an exterior surface of the body to an interior surface of the body, and at least one internal rib extending inwardly from the interior surface, the rib configured to contact the medical device.

Abstract: A pellet delivery system is provided that comprises a needle having an inner surface defining a passageway. The needle has a first portion that extends along a longitudinal axis and a curved second portion comprising an opening that is in communication with the passageway. The second portion extends transverse to the longitudinal axis. A pellet is positioned in the passageway. A plunger is slidably positioned in the passageway. The plunger comprises a shaft having a rounded tip configured to push the pellet through the first and second portions and out of the opening without the pellet becoming stuck within the passageway or the opening. Implants, systems, constructs, instruments and methods are disclosed.

Abstract: Described herein is a liquid embolic delivery device designed to minimize excess embolic solvent buildup therein. The liquid embolic delivery device generally comprises an outer catheter, an inner catheter that is longitudinally moveable within the outer catheter. The inner catheter is used for an initial embolic solvent flush and to deliver liquid embolic, while the outer catheter is used to remove excess solvent.

Abstract: Certain embodiments are directed to a formulation of a therapeutic agent, as well as a method of making such a formulation, comprising at least one therapeutic agent dissolved in an aprotic polar solvent system comprising at least one ionization stabilizing excipient in a concentration sufficient to impart physical and chemical stability to the therapeutic agent.

Abstract: A device for applying a tissue healing agent includes an insertion member extending longitudinally from a proximal end to a distal end and including a channel extending therethrough, a delivery element including a first surface and a second surface opposing one another, the delivery element movable between a closed configuration, in which the delivery element is compressed to be received within the channel, and an open configuration, in which the delivery element is substantially planar, and a first tissue healing agent formed in a sheet configuration and disposed on the first surface of the delivery element.

Abstract: Drug depot delivery devices and methods for delivering a drug depot to a site beneath the skin of a patient are provided. In various embodiments the device has a housing having a top housing end, and a bottom housing end. The housing defines a housing channel. The device has a drug cartridge defining a depot channel aligned with the housing channel and configured to slidably accept the drug depot. The drug cartridge has at least a first occluding device configured to occlude the depot channel at a first position such that the drug depot cannot pass through the depot channel without force applied to the drug depot sufficient to deflect the first occluding device. The bottom end of the housing has a coupling configuration for engaging a cannula. A plunger has a push rod to expel the drug depot through the occluding device and the cannula.

Abstract: Disclosed is a stable liquid formulation for parenteral injection comprising a biocompatible non-aqueous solvent and a small molecule drug, or a salt thereof, solubilized within the non-aqueous solvent, wherein the liquid formulation comprises less than 10% by weight residual water, and wherein the volume of the liquid formulation to be parenterally injected is from 0.1 ?l to 3 ml.

Abstract: Aspects of the present disclosure are directed toward apparatuses, systems, and methods that comprise an introducer apparatus for facilitating subcutaneous implantation of a medical device. In certain instances, the apparatus may include a housing, an inserter configured to pass the medical device through the housing, and a tunneler configured to form a subcutaneous pocket for the medical device.

Abstract: An insertion tool facilitating assembly of a surgical instrument includes a housing defining a distal end portion, a proximal end portion, and a central lumen. The central lumen extends therethrough the housing between a distal opening and a proximal opening, and defines a proximal portion and a distal portion. The central lumen is configured to receive a portion of a pin within the distal portion thereof. The insertion tool further includes retention channel defined about the housing at the distal end portion thereof. The retention channel is in communication with the central lumen. A D-ring is at least partially seated within the retention channel and extends into the distal portion of the central lumen to retain the pin therein by applying a compressive force to the pin. A plunger is configured to slide through the central lumen to deploy the pin distally from the distal opening of the central lumen.

Abstract: Systems, methods, and devices for inserting an intraocular lens (IOL) assembly into an eye may be provided. A device for delivery of the IOL into the eye may include a housing; a nozzle operatively coupled to the housing; a first cylinder movably disposed within the housing; a second cylinder movably disposed within the housing, wherein the second cylinder is in fluid communication with the first cylinder; a plunger at least partially and movably disposed within the first cylinder; and a shaft movably disposed within the second cylinder, wherein the shaft is configured to move toward the lens component.

Abstract: Subcutaneous implantation tools and methods of implanting a subcutaneous device using the same. The tool may include a tool body having a longitudinally extending recess having a distal opening and having a tunneler at a distal end of the tool body extending from the distal opening of the recess. The tool may include a plunger slidably fitting within at least a portion of the tool body recess. The recess may be configured to receive an implantable device and the tunneler preferably extends distally from the recess at a position laterally displaced from the device when the device is so located in the recess. Movement of the plunger distally within the recess advances the device distally out of the recess and alongside of and exterior to the tunneler.

Abstract: This invention relates to methods of administering oral octreotide therapy to a female subject relating to avoidance of combined oral contraceptives or use of a back-up method for contraception.

Abstract: An apparatus includes a housing and a pushrod. The housing defines a delivery passage and an exit port in fluid communication with the delivery passage. At least a portion of the pushrod is movably disposed in the delivery passage. A distal end portion of the pushrod is configured to move a drug dosage form through at least a portion of the delivery passage to convey the drug dosage form through the exit port when the distal end portion of the pushrod is moved from a first position to a second position. A surface of at least one of the pushrod or the housing defining the delivery passage is nonplanar, curved and/or contoured.

Abstract: Stable formulations for parenteral injection of peptide drugs and methods of using such stable formulations are provided. In particular, the present invention provides stable formulations for parenteral injection of glucagon and methods of using such glucagon formulations to treat hypoglycemia, especially severe hypoglycemia in emergency situations.

Abstract: Medical devices for delivering compositions or medical articles to a patient are disclosed. The medical plug delivery devices can include a fluid delivery device (e.g., a syringe), a frame, and a rotatable magazine. The rotatable magazine can include a plurality of chambers that each hold a composition or a medical article (e.g., a medical plug). By rotating the rotatable magazine relative to the frame, material within the chambers of the rotatable magazine can be sequentially deployed to a patient.

Abstract: Provided is technology which can prevent the circumferential section of the end surface of a tip end opening from being damaged when an intraocular lens is extruded from an insertion apparatus, even when an insertion tube of the intraocular lens insertion apparatus has been further reduced in size.

Abstract: An injection includes a tube having opposite first and second ends. A hub is coupled to the first end. A sheath is coupled to the tube and the hub. The hub is movable relative to the tube to move the sheath between a first orientation in which the sheath covers an orifice in the second end and a second orientation in which the sheath is spaced apart from the orifice. Kits and methods of use are disclosed.

Abstract: Disclosed is a stable liquid formulation for parenteral injection comprising a biocompatible non-aqueous solvent and a small molecule drug, or a salt thereof, solubilized within the non-aqueous solvent, wherein the liquid formulation comprises less than 10% by weight residual water, and wherein the volume of the liquid formulation to be parenterally injected is from 0.1 ?l to 3 ml.

Abstract: A device for applying a tissue healing agent includes an insertion member extending longitudinally from a proximal end to a distal end and including a channel extending therethrough, a delivery element including a first surface and a second surface opposing one another, the delivery element movable between a closed configuration, in which the delivery element is compressed to be received within the channel, and an open configuration, in which the delivery element is substantially planar, and a first tissue healing agent formed in a sheet configuration and disposed on the first surface of the delivery element.

Abstract: An arthroscopic drill for insertion into a human joint of a human body comprising an elongate body extending between a proximal end which, during use, remains external to the human body and a distal end which, when in an operative configuration, is positioned in the human joint adjacent to a target structure within the human body (e.g. preferably a joint surface); a drill bit having a proximal portion adjacent the distal end of the elongated body, the drill bit having a distal portion extending to the target structure; and an introducer sheath having a lumen with an inner diameter of at least 2 mm and a bending stiffness of approximately 0.08 Nm2, wherein the operative configuration, the elongate body extends through the introducer sheath.

Abstract: A device for delivering a drug depot into a patient via a cannula is provided. The device includes a housing with a coupling mechanism. A drug cartridge is positioned within the housing and includes a cartridge depot channel having an occluding device that includes a ramp and a plateau. The occluding device occludes the cartridge depot channel to prevent the drug depot from moving beyond the occluding device without force applied to the drug depot sufficient to deflect the occluding device an amount to allow the drug depot to move beyond the occluding device. The drug cartridge includes an alignment boss with an end channel coaxial with the cartridge depot channel. A push rod is slidably receivable in the housing and the drug cartridge to move the drug depot beyond the occluding device, into the cartridge depot channel, through the cannula and into the patient.

Abstract: A method for repairing a cartilage defect according to an exemplary aspect of the present disclosure includes, among other things, preparing a cartilage defect for implantation of a cartilage graft and attaching the cartilage graft to bone using at least one knotless suture anchor.

Abstract: Certain embodiments are directed to a formulation of a therapeutic agent, as well as a method of making such a formulation, comprising at least one therapeutic agent dissolved in an aprotic polar solvent system comprising at least one ionization stabilizing excipient in a concentration sufficient to impart physical and chemical stability to the therapeutic agent.

Abstract: Methods and devices are disclosed herein that generally provide protection for devices (e.g., microcatheters) having small tips. Methods and devices are also disclosed herein that generally facilitate use of commercially-available stereotactic systems with devices (e.g., microcatheters) having small tips.

Abstract: Insertion tool for a medical closure device for the sealing of an opening in a wall of a bodily organ, comprising a tamping force source adapted to deliver a first member to a position at the opening on one side of the wall subsequently to a second member being positioned at the opening on the opposite side of the wall. The tamping force source, which is energized prior to the tamping procedure, can be a spring, an elastic band or a pressurized gas container. A tamping spring can be compressed or extended upon loading. The tamping force source can be released in response to a manual operation or be triggered by retraction of the insertion tool.

Abstract: The devices and methods described herein relate to injector devices for delivering payloads to a tissue.

Abstract: A marking device includes a handle defining a hollow interior, and a delivery assembly slidably mounted to the handle. The delivery assembly includes a cannula, a stylet assembly, an imaging marker, and an actuator. The cannula has a cannula distal end with a marker recess. The imaging marker is disposed within the marker recess. The actuator is operably coupled to the delivery assembly and is operable to transition the delivery assembly through at least three configurations: a first configuration characterized in that the cannula is positioned in an extended position and the stylet assembly is positioned in a ready position; a second configuration characterized in that the cannula is positioned in the extended position and the stylet assembly is positioned in an implant position; and a third configuration characterized in that the cannula is positioned in the retracted cannula position and the stylet is retracted into the handle.

Abstract: An occluding device for occluding fluid flow through a lumen of a body vessel. The device comprises a coil and fibers attached to the coil. The coil has about 5 to 60 grams of initial tension to facilitate the coil to fold when deployed. The fibers extend from the coil at a length.

Abstract: The invention relates to a method for producing a device containing a needle that poses an injury risk, which is equipped with a protective mechanism. The method comprises the following steps, which may be carried out in any order: a) provision of at least one film, b) connection of the film to a protective device to form a protective mechanism, and c) fixing of the protective mechanism to the device, whereby at least part of the surface of the film can be fixed directly or indirectly to the device. The invention also relates to a protective mechanism for a device containing a needle that poses an injury risk, the device comprising at least one film, in addition to an assembly of protective mechanisms, in which the protective mechanisms are directly or indirectly connected.

Abstract: A method and apparatus for suture-less placement of an occluding patch in which release of the device can be accelerated. In one embodiment, an inactive form of an adhesive is applied on the area of the patch that will come into contact with cardiac tissue; this allows for the introduction and necessary manipulation of the catheter system until activation of the adhesive occurs. In accordance with one aspect of the invention, the adhesive properties of certain polymeric materials are relied upon rather than their ability to cure or harden into a specific shape. In another embodiment, the patch is immediately released utilizing a detaching mechanism on the balloon or the balloon catheter which supports the patch; the patch along with the inflated balloon remain on the cardiac structure occluding the opening.

Abstract: A container suitable for dispensing dispensable moisture sensitive curable products such as a CA with a container body which forms an internal reservoir for holding the product a dispensing aperture provided in the container body. Opposing side wall have a curved profile along its path between the front and rear walls which is arranged to regulate a compressibility ratio between the compressive force regulated to move at least one of the front and rear walls toward the other and the distance compressed so that a yield point is not reached, within a compressive dispensing range of movement of said at least one wall, beyond which the container becomes substantially easier to compress. The dispensing force required is predictable and regular while a desired flexibility is achieved.

Abstract: An optimized breast implant injector includes a hollow tube body and a plunger. The hollow tube body has a short tube reducer at one end and a circular disk at the other end. The plunger includes a push block, a driving device, and two fixed covers. The outer surface of the push block appears to be a circular arc shape. The driving device includes a rotating part, and a driving gear, a driven gear and a rack that mesh together. A user uses the rotating part to easily start the driving gear, the driven gear, and the rack, in order to let the rack drive the push block to move the breast implant in the hollow tube body. Through operating a short tube reducer of the hollow tube body and the push block, the breast implant can be pushed through from the short tube reducer easily.

Abstract: Certain embodiments are directed to a formulation of a therapeutic agent, as well as a method of making such a formulation, comprising at least one therapeutic agent dissolved in an aprotic polar solvent system comprising at least one ionization stabilizing excipient in a concentration sufficient to impart physical and chemical stability to the therapeutic agent.

Abstract: Disclosed is a composition for parenteral administration comprising a glucagon peptide which has been dried in a non-volatile glycine buffer, and wherein the glucagon peptide has a pH memory that is about equal to the pH of the glucagon peptide in the non-volatile buffer, wherein the pH memory is between 2.5 to 3.5, an aprotic polar solvent, wherein the peptide is solubilized in the aprotic polar solvent, and wherein the aprotic polar solvent is dimethyl sulfoxide (DMSO), trehalose, glycine, and optionally hydrochloric acid, wherein the moisture content of the composition is less than 5 wt. %.

Abstract: A transcutaneous implant tool is used to push a medical element through an incision and into a patient's subcutaneous tissue, while a fin of the tool is engaged beneath the patient's skin at the incision site. The tool preferably includes an injection rod for moving the medical element out through an opening of a bore of the tool. The fin, which is located in proximity to the opening, preferably includes a distal-facing surface that extends proximally from the opening at an acute angle with respect to a longitudinal axis of the bore; and the injection rod preferably includes a distal surface that is approximately coplanar with the distal-facing surface of the fin, when the distal surface of the rod is located in proximity to the opening of the bore.

Abstract: Disclosed in some embodiments are instruments and associated methods for the subchondral treatment of defects near a peripheral articular surface of a joint.

Abstract: A device implantable in tissue of a prostate gland or a bladder is described. The device includes a device body, a retrieval portion, a medicament, and a medicament carrier. The device body includes a first end and a second end opposite of the first end. The first end has a sharp tip adapted for penetrating the tissue. The retrieval portion connected to the second end of the device body. The medicament is applied to the device to therapeutically treat the prostate gland or the bladder. The carrier is a hydrogel, a silicone based material, an elastomer, a proteinaceous material, a polyethylene glycol material, a carbohydrate material, or a polysaccharide carbohydrate material that provides controlled delivery of the medicament over a duration of time.

Abstract: Stable formulations for parenteral injection of peptide drugs and methods of using such stable formulations are provided. In particular, the present invention provides stable formulations for parenteral injection of glucagon and methods of using such glucagon formulations to treat hypoglycemia, especially severe hypoglycemia in emergency situations.

Abstract: Stable formulations for parenteral injection of peptide drugs and methods of using such stable formulations are provided. In particular, the present invention provides stable formulations for parenteral injection of glucagon and methods of using such glucagon formulations to treat hypoglycemia, especially severe hypoglycemia in emergency situations.

Abstract: Stable formulations for parenteral injection of peptide drugs and methods of using such stable formulations are provided. In particular, the present invention provides stable formulations for parenteral injection of glucagon and methods of using such glucagon formulations to treat hypoglycemia, especially severe hypoglycemia in emergency situations.

Abstract: Disclosed is a formulation for parenteral administration comprising insulin that comprises a pH memory between 1 to 4 or between 6 to 8 and an aprotic polar solvent, wherein the insulin is solubilized in the aprotic polar solvent, wherein the solubilized insulin comprises stable monomeric or dimeric forms of insulin or mixtures thereof, and wherein the water content of the formulation is equal to or less than 15% w/v.

Abstract: Disclosed is a stable liquid formulation for parenteral injection comprising a biocompatible non-aqueous solvent and a small molecule drug, or a salt thereof, solubilized within the non-aqueous solvent, wherein the liquid formulation comprises less than 10% by weight residual water, and wherein the volume of the liquid formulation to be parenterally injected is from 0.1 ?l to 3 ml.

Abstract: Improved methods and apparatuses for treatment of incontinence or pelvic organ prolapse are provided. A neo ligament for increasing the supportive function of the tissues supporting the urethra, bladder neck, or rectum is disclosed. Methods of using such a neoligament to treat incontinence are disclosed. Additionally, a self tensioning elastic tissue bolster for support of the tissues that support the urethra, rectum, and bladder neck are disclosed. A method of treating incontinence by injecting proliferative agents into supportive structures is disclosed. Methods and apparatus for transvaginal and transperineal pelvic floor bolster treatment of incontinence and bladder pillar systems are also disclosed.

Abstract: A bioresorbable drug eluting intravitreal implant system includes a syringe with a chamber containing a medicinal drug. A balloon is releasably secured to a needle where the needle has a central section chamber in fluid communication with a chamber in the syringe. The needle central section has an opening formed through a wall for transporting the medicinal drug to the interior of the balloon subsequent to insertion of the needle through the sclera of a patient's eye.

Abstract: This application relates to a cannula (78) comprising a bevelled cannula tip (80) at the distal end and a cannula holder (16) holding the cannula (78) at the proximal end, as well as a stylet unit (82), which can be displaced from a starting position to an end position in the cannula (78), wherein the cannula (78) is particularly intended to deposit at least one element (18, 20) in a body. According to the invention, in order to ensure simple and reliable protection of the cannula tip as well as a locking of the stylet unit in the end position, the distal end (84) of the stylet unit protrudes a distance (A) beyond the cannula tip (80) in the end position and the stylet unit (82) is fixed in the end position while simultaneously covering the bevelled cannula tip (80).

Abstract: The bioinjection device has a housing including a pistol grip and an elongated barrel. A trigger is pivotally mounted to the housing. A plunger and needle are slidable between a first position in which the plunger and needle are slidably disposed in the barrel and a second position in which the plunger and needle extend from an opening in the end of the barrel. A retaining member is disposed about the opening at the end of the barrel. A spring-biased actuation mechanism connects the trigger with the plunger and needle. A membranous cartridge containing bone morphogenic protein, antibiotics, and/or other medication is loaded into the retaining member. A surgeon can inject the cartridge into a bone fracture or degenerative bone tissue during surgery to deliver the medicament directly to the affected site.

Abstract: Systems and methods for administration of small volume sufentanil drug dosage forms to the sublingual mucosa of a subject using a device are disclosed. The dispensing device includes a lock-out feature and a means to retard or prevent saliva and/or moisture ingress such that the drug dosage forms in the device remain dry prior to administration.

Abstract: Pre-loaded syringes for delivering an embolic agent are disclosed herein. Methods related to syringes pre-loaded with an embolic agent are also disclosed.

Abstract: A method for delivering particles to a target location of a subject includes slidably disposing a polymeric carrier in a lumen of a catheter. The lumen extends in the catheter from a proximal opening to a delivery region. The method further includes inserting the delivery region of the catheter in the target location of the subject and forcing the particles through the lumen of the catheter to cause the carrier and the particles to exit the delivery region of the catheter. The particles may be cells or drug-loaded microspheres. The carrier can serve to retain the particles in the target location for a period of time. For treatment of vertebral disc degeneration, the particles can be stem cells, the carrier can be formed from collagen, and the target location can be the nucleus pulposus.